Login to Your Account

Chiron Licenses From Novartis An Aerosolized Cyclosporine

By Kim Coghill

Wednesday, April 23, 2003
Taking the opportunity to leverage its commercial expertise with the product TOBI, Chiron Corp. acquired exclusive worldwide development and commercial rights to a product being developed by Novartis AG. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription